Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Clinical trial NCT01429441 · COMPLETED

Trial details

NCT number: NCT01429441
Sponsor: ThromboGenics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vitreomacular Adhesion Including Macular Hole

Start date: 2011-10-01
Primary completion: 2014-10-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.